Диссертация (1141039), страница 20
Текст из файла (страница 20)
Oral Microbiol. – 2014. – Vol. 6. – P. 1-10.172. Goel, A. Gut microbiota and liver disease / A. Goel, M. Gupta, R.Aggarwal // J. Gastroenterol. Hepatol. – 2014. – Vol. 29, N 6. – P. 1139-1148.173. Hawrelak, J.A. The Causes of intestinal dysbiosis: a review / J.A.Hawrelak, S.P. Myers // Alternative Med. Rev. – 2004. – Vol. 9, N 2. – P. 180-197.113174. Hopkins. M.J. Age and disease related changes in interstinal bacterialpopulations assessed by cell culture, 16S rRNA abundance, and community cellularfatty acid profiles / M.J. Hopkins // Gut. – 2001.
– Vol. 48, N 2. – P. 198-205.175. Influence of a probiotic mixture on antibiotic induced microbiotadisturbances / S. Forssten [et al.] // World. J. Gastroenterol. – 2014. – Vol. 20, N 33. –P. 11878-11885.176. Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridiumdifficile Infection and Nosocomial Diarrhea / V.C. Antharam [et al.] // J. Clin.Microbiol. – 2013. – Vol. 51, N 9. – P.
2884-2892.177. Intestinal dysbiosis associated with systemic lupus erythematosus / A.Hevia [et al.] // mBio. – 2014. – Vol. 5, N 5. – P. 1-10.178. Intestinal microbiota in human health and disease: the impact of probiotics /J. Gerritsen [et al.] // Genes Nutr. – 2011. – Vol. 6, N 3. – P. 209-240.179. Intestinal microbiota pathogenesis and fecal microbiota transplantation forinflammatory bowel disease / W.
Zi-Kai [et al.] // World. J. Gastroenterol. – 2014. –Vol. 20, N 40. – P. 14805-14820.180. Intestinal Microbiota, Probiotics and Prebiotics: Comprehensive Textbookfor Health Professionals / ed. Rok Orel. – Ljubljana, Slovenia. 2014. – 299 p.181. Isolauri, E. Probiotics: a role in the treatment of intestinal infection andinflammation / E.
Isolauri, P.V. Kirjavainen, S. Salminen // Gut. – 2002. – Vol. 50, N 3.– P. 54-59.182. Kiefer, C.R.Oxidation and erythrocyte senescence / C.R. Kiefer, L.M.Snyder// Curr. Opin. Hematol. – 2000. – Vol. 7, N 2. – P. 113-116.183. Lombard, J. The early evolution of lipid membranes and the three domainsof life / J. Lombard, P. López-Garcίa, D. Moreira // Nat. Rev. Microbiol.
– 2012. – Vol.10, N 7. – P. 507-522.184. Mawatari, S.Absence of correlation between glycated hemoglobin and lipidcomposition of erythrocyte membrane in type 2 diabetic patients / S. Mawatari, K.Saito, K. Murakami// Metabolism. – 2004. – Vol. 53, N 1. – P. 123-127.114185. Microbial Dysbiosis Is Associated with Human Breast Cancer / C. Xuan [etal.] // PLoS ONE. – 2014. – Vol.
9, N 1. – P. 1-7.186. Mugambi, M.N. Application of evidence on probiotics, prebiotics andsynbiotics by food industry: a descriptive study / M.N Mugambi, T. Young, R. Blaauw1// BMC Res. Not. – 2014. – Vol. 7. – P. 754-762.187. O’Hara, А.М.
Кишечная микрофлора: анализ терапевтическогопотенциала / A.M. O’Hara, F. Shanahan // Клиническая гастроэнтерология игепатология. – 2008. – Т. 1, № 4. С. 236-247.188. Orel, R. Intestinal microbiota, probiotics and prebiotics in inflammatorybowel disease / O. Rok, T. Kamhi Trop // World. J. Gastroenterol. – 2014. – Vol.
20, N33. – P. 11505-11524.189. Phosphatidic acid mediates the targeting of tBid to induce lysosomalmembrane permeabilization and apoptosis / K. Zhao [et al.] // Lipid Res. – 2012. – Vol.53, N 10. – P. 2102-2116.190. Probiotics – a helpful additional therapy for bacterial vaginosis / O. Bodean[et al.] // J. Med. Life. – 2013. – Vol. 6, N 4. – P. 434-436.191. Quantification of selective phosphatidylserine oxidation during apoptosis /J.P. Fabisiak [et al.] // Methods. Mol. Biol.
– 2005. – Vol. 291. – P. 449-456.192. Role of membrane lipids for the activity of pore forming peptides andproteins / G. Fuertes [et al.] // Adv. Exp. Med. Biol. – 2010. – Vol. 677, N 2. – P. 31-55.193. Santos, H.A. Electrochemical properties of phospholipid monolayers atliquidliquid interfaces / H.A. Santos, V. Garsia-Morales, C.M. Pereira //Chemphyschem. – 2010. – Vol. 11, N 1. – P. 28-41.194. The administration of probiotics and synbiotics in immune compromisedadults: is it safe? / M. van den Nieuwboer [et al.] // Beneficial Microbes. – Vol. 1, N 1.– P.
1-15.195. The overarching influence of the gut microbiome on end-organ function:the role of live probiotic cultures / L. Vitetta [et al.] //Pharmaceuticals. – 2014. – Vol.7,N 9. – P. 954-989.115196. Tsuda, K.Insulin and membrane microviscosity of erythrocytes as riskfactors for stroke / K. Tsuda // Stroke. – 2003.
– Vol. 34, N 12. – Р. 225 226.197. Vaishnavi, C. Translocation of gut flora and its role in sepsis / C. Vaishnavi// Indian J. Med. Microbiol. – 2013. – Vol. 31, N 4. – P. 334-342.198. Wahid, S.T. Increased platelet and erythrocyte external cell membranephosphatidylserine in type 1 diabetes and microalbuminuria / S.T. Wahid, S.M.Marshall, T.H. Thomas // Diabet. Care. – 2001. – Vol.
24, N 11. – P. 2001-2003.199. Yang, Y. Microbial imbalance and intestinal pathologies: connections andcontributions / Y. Yang, C. Jobin. // Dis. Models Mechanisms. – 2014. – Vol. 7, N 10. –P. 1131-1142..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
